Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 129101 - 129120 out of 566103 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (L01BC52) fluorouracil, combinations | Actikerall | Liq/Liq. Top 0.5% / 10%,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CIP |
| Canada | (L01EA06) asciminib (adm: O) | Scemblix | Tab/Co. Orl 20 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NVR |
| Canada | (L01EA06) asciminib (adm: O) | Scemblix | Tab/Co. Orl 40 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NVR |
| Canada | (L01EB04) osimertinib (adm: O) | Tagrisso | Tab/Co. Orl 40 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AZE |
| Canada | (L01EB04) osimertinib (adm: O) | Tagrisso | Tab/Co. Orl 80 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AZE |
| Canada | (L01EC01) vemurafenib (adm: O) | Zelboraf | Tab/Co. Orl 240 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | HLR |
| Canada | (L01ED01) crizotinib (adm: O) | Xalkori | Cap/Caps. Orl 200 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PFI |
| Canada | (L01ED01) crizotinib (adm: O) | Xalkori | Cap/Caps. Orl 250 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PFI |
| Canada | (L01ED03) alectinib (adm: O) | Alecensaro | Cap/Caps. Orl 150 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | HLR |
| Canada | (L01EE02) cobimetinib (adm: O) | Cotellic | Tab/Co. Orl 20 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | HLR |
| Canada | (L01EH01) lapatinib (adm: O) | Tykerb | Tab/Co. Orl 250 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NVR |
| Canada | (L01EH03) tucatinib (adm: O) | Tukysa | Tab/Co. Orl 150 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SGC |
| Canada | (L01EH03) tucatinib (adm: O) | Tukysa | Tab/Co. Orl 50 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SGC |
| Canada | (L01EJ04) momelotinib (adm: O) | Ojjaara | Tab/Co. Orl 100 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GSK |
| Canada | (L01EJ04) momelotinib (adm: O) | Ojjaara | Tab/Co. Orl 150 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GSK |
| Canada | (L01EJ04) momelotinib (adm: O) | Ojjaara | Tab/Co. Orl 200 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GSK |
| Canada | (L01EK01) axitinib (adm: O) | Inlyta | Tab/Co. Orl 1 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PFI |
| Canada | (L01EK01) axitinib (adm: O) | Inlyta | Tab/Co. Orl 5 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PFI |
| Canada | (L01EL02) acalabrutinib (adm: O) | Calquence | Tab/Co. Orl 100 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AZE |
| Canada | (L01EL03) zanubrutinib (adm: O) | Brukinsa | Cap/Caps. Orl 80 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Waldenstrom Macroglobulinemia | BEO |
Pages
